FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer“On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle (Imdelltra, Amgen Inc.) for adults with extensive stage small cell lung...
A mild symptom was bothering a young dad. He had Stage IV lung cancer.“Endurance athlete Kevin Humphrey was used to discomfort. He regularly participated in ultramarathons and other intense events. Swimming, biking and running dozens of miles at a time was standard...
LUNGevity Foundation Launches 2025 Lung Cancer Awareness Month with 60,000 White Flags on the National Mall in Washington DC“WASHINGTON, Nov. 3, 2025 /PRNewswire/ — This November, during Lung Cancer Awareness Month (LCAM), LUNGevity Foundation will lead a...
The New Lung Cancer Divide: Rural, Low-Income Young Adults Left Behind“A sweeping U.S. analysis of 18,595 people aged 18–50 diagnosed with early-onset non–small cell lung cancer (NSCLC) has a blunt message: outcomes hinge not only on tumor biology but on where you...
Personalized cancer vaccines: A new frontier in lung cancer treatment and prevention“Despite declining tobacco use, lung cancer remains the leading cause of cancer-related death worldwide. As oncologists seek more-effective and individualized therapies, Mayo Clinic...
More News and Updates